The use of nanoparticles (NPs) has surely grown in recent years due to their versatility, with
a spectrum of applications that range from nanomedicine to the food industry. Recent …

The increasing desire for oral delivery vehicle systems encouraged the development of
micro and nano encapsulation technologies to protect drugs against gastric and enzymatic …

About ninety percent of all diabetic conditions account for T2D caused due to abnormal
insulin secretion/action or increased hepatic glucose production. Factors that contribute …

Rutin is a natural antioxidant compound with several therapeutic benefits. However, the
application of this bioactive compound is limited due to its low stability and bioavailability. To …

Chitosan-stabilized selenium nanoparticles (CTS-SeNPs) were prepared through the
reduction of selenite acid with ascorbic acid. The optimal synthesis conditions of CTS …

Betanin is a bioactive compound with a high antioxidant activity and therapeutic potential.
However, incomplete oral absorption and low stability of betanin limit its application. To …

Diabetic nephropathy (DN) is one of the most serious complications of diabetes mellitus. The
combination of insulin (Ins) with liraglutide (Lir) has a greater potential for preventing DN …

The current scenario has seen many transformative changes in target-based drug delivery
system. In this direction, encapsulation of medicines in nanoparticles has almost …

Diabetes mellitus (DM) could negatively affect patients' health via inducing a lot of serious
functional hazards in many tissues' cells at molecular levels. Recently, many scientists had …

Oral delivery of insulin-loaded therapeutics is challenging due to the extreme pH condition,
enzymatic degradation, and limited permeation in the gastrointestinal (GI) tract …